IRIS
RIZZOLI, Vittorio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.361
EU - Europa 3.508
AS - Asia 2.351
AF - Africa 42
Continente sconosciuto - Info sul continente non disponibili 15
SA - Sud America 3
OC - Oceania 2
Totale 10.282
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.259
CN - Cina 1.423
IE - Irlanda 758
SE - Svezia 716
FI - Finlandia 708
SG - Singapore 596
UA - Ucraina 551
DE - Germania 467
TR - Turchia 253
IT - Italia 106
CA - Canada 101
GB - Regno Unito 67
CI - Costa d'Avorio 39
FR - Francia 38
IN - India 36
BE - Belgio 30
RO - Romania 25
IR - Iran 22
EU - Europa 15
CZ - Repubblica Ceca 9
NL - Olanda 9
LV - Lettonia 5
HK - Hong Kong 4
JP - Giappone 4
SK - Slovacchia (Repubblica Slovacca) 4
ES - Italia 3
IL - Israele 2
KZ - Kazakistan 2
LT - Lituania 2
NG - Nigeria 2
PL - Polonia 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
AU - Australia 1
BD - Bangladesh 1
BG - Bulgaria 1
BR - Brasile 1
CH - Svizzera 1
CM - Camerun 1
GR - Grecia 1
HR - Croazia 1
HU - Ungheria 1
KG - Kirghizistan 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
MN - Mongolia 1
MX - Messico 1
NZ - Nuova Zelanda 1
PE - Perù 1
PH - Filippine 1
PK - Pakistan 1
RS - Serbia 1
Totale 10.282
Salva come PNG Salva come JPEG
Città #
Dublin 758
Chandler 711
Jacksonville 654
Singapore 470
Santa Clara 355
Beijing 297
Ashburn 256
Dearborn 253
Nanjing 235
Izmir 226
Boardman 219
San Mateo 186
Princeton 160
Ann Arbor 141
Wilmington 98
Toronto 96
Shanghai 95
Shenyang 87
Nanchang 81
Kunming 74
Helsinki 67
Hebei 65
Düsseldorf 63
Jinan 62
Hefei 58
Des Moines 49
Parma 47
Woodbridge 40
Abidjan 39
New York 38
Marseille 37
Changsha 35
Jiaxing 35
Tianjin 34
Bremen 33
Los Angeles 32
Brussels 30
Kocaeli 26
Pune 26
Leawood 25
Guangzhou 24
Seattle 24
Grafing 22
Zhengzhou 21
Munich 20
Hangzhou 19
Norwalk 19
Augusta 18
Ningbo 16
Focsani 15
Mestre 14
Monmouth Junction 13
Ardabil 12
Fremont 12
Haikou 12
Houston 11
Lanzhou 11
Fuzhou 10
Taizhou 10
Timisoara 10
Dallas 9
Auburn Hills 8
Borås 8
Brno 7
Chongqing 7
Frankfurt am Main 7
Milan 7
Taiyuan 7
Amsterdam 6
Chengdu 6
Edinburgh 5
Riga 5
Trezzano Sul Naviglio 5
Wuhan 5
Bratislava 4
Cambridge 4
Rockville 4
Sabz 4
Southend 4
Torrile 4
Xian 4
Baotou 3
Chicago 3
Jinhua 3
Kyoto 3
Madrid 3
Montréal 3
Mumbai 3
Orange 3
Orta di Atella 3
Shaoxing 3
Ahmedabad 2
Almaty 2
Bergamo 2
Bologna 2
Changchun 2
Harbin 2
Hong Kong 2
Lagos 2
London 2
Totale 6.774
Salva come PNG Salva come JPEG
Nome #
Angiopoietin-1 and Osteopontin Expression by CD138+ Myeloma Cells Rather Than VEGF and CD45 Correlates with Bone Marrow Angiogenesis in Multiple Myeloma Patients at the Diagnosis 123
Are the Myeloma bone microevironment cells tumoral or not? 114
Hypoxia and Hypoxia Inducible Factor (HIF)-1{alpha} in Multiple Myeloma: Effect on the Pro-Angiogenic Signature of Myeloma Cells and the Bone Marrow Microenvironment 114
Diabetes impairs hematopoietic stem cell mobilization by altering niche function 113
Co-existence of Philadelphia chromosome positive acute megakaryoblastic and B-lymphoblastic mixed blast crisis of chronic myeloid leukemia with chronic lymphocytic leukemia 110
HOXB7 expression by myeloma cells regulates their pro-angiogenic properties in multiple myeloma patients 104
CC-4047 (Pomalidomide) inhibits multiple myeloma-induced osteoclast formation targeting RANKL in the bone marrow microenvironment 103
Human myeloma cells produce angiopoietin-1 but not angiopoietin-2: potential relationship with myeloma-induced angiogenesis 101
Hypoxia and hypoxia inducible factor (HIF)-1α in Multiple Myeloma patients: role in the angiogenic switch 101
HOXB7 is a key gene involved in Myeloma cell growth and Myeloma-induced angiogenesis in Multiple Myeloma patients 99
Activation of non-canonical wnt pathway in human mesenchymal cells affects osteogenic differentiation: a potential target in Multiple Myeloma microenvironment 98
The homeobox gene HOXB7 regulates the production of pro-angiogenic molecole by myeloma cells and it is a target in myeloma-induced angiogenesis 97
Chemokine receptors CXCR3 and CXCR4 expression in B cell and plasma cell malignancy 96
Bone marrow endothelial cells carry bcr/abl fusion gene from chronic myeloid leukemia patients 95
The Immunomodulatory drugs Lenalidomide and Pomalidomide inhibit multiple myeloma-induced osteoclast formation and RANKL/OPG ratio in myeloma microenvironment targeting the expression of adhesion molecules 94
The IMID CC-4047 (Pomalidomide) inhibits myeloma-induced osteoclast formation 94
Angiopoietins expression by human myeloma cells 93
BCR/ABL fusion gene is detected in chronic myeloid leukemia endothelial cells 93
IL-7 is induced by IL-6 in human myeloma cells: role in multiple myeloma 89
Analysis of lineage involvment in Philadelphia chromosome positive acute lymphoblastic leukaemia 86
Hematologic malignancies with extramedullary spread of disease. Case 1. Multiple myeloma with extramedullary involvement of the pleura and testes 86
Oxygen tension in the bone marrow (BM) of patients with malignant and indolent monoclonal gammopathy: role of hypoxia and hypoxia-inducible factor (HIF)-1{alpha} in the regulation of gene expression and pro-angiogenic profiles of CD138+ cells 86
Angiopoietin-1 and osteopontin expression by CD138+myeloma cells rather than VEGF and CD45 correlates with bone marrow angiogenesis in Multiple Myeloma patients at the diagnosis. 86
Myeloma cells block RUNX2/CBFA1 activity in human bone marrow osteoblast progenitors and inhibit osteoblast formation and differentiation 84
Angiogenic switch in multiple myeloma patients 84
HOXB7 is critically involved in Multiple Myeloma-induced angiogenic switch 84
Pro-angiogenetic properties of human myeloma cells: production of angiopoietin-1 and its potential relationship with myeloma-induced angiogenesis 83
Autologous transplant for chronic myelogenous leukemia using marrow treated ex vivo with mafosfamide. 82
Amifostine (WR-2721) selective protection against melphalan genotoxicity 81
Angiogenic properties of human myeloma cells: role of angiopoietin system 81
Non canonical wnt signal pathway (Wnt5a/ror2) activation stimulates the osteogenic differentiation process of bone mesenchymal cells being a potential target in multiple myeloma bone disease 81
Do human myeloma cells directly produce basic FGF? 81
VASCULAR ENDOTHELIAL GROWTH FACTOR SECRETION BY MYELOMA CELLS IS INHIBITED BY DOWN-MODULATING ERK PROTEIN KINASE ACTIVITY 79
Angiopoietin-1 and myeloma-induced angiogenesis 79
CC-Chemokine Ligand 20/Macrophage Inflammatory Protein-3A and CC-Chemokine Receptor 6 Are Overexpressed in Myeloma Microenvironment Related to Osteolytic Bone Lesions 79
Expression and role of chemokine receptor CXCR3 in multiple myeloma 79
Ectopic production of osteopontin by human myeloma cells and its involvement in myeloma induced angiogenesis 79
Osteopontin is produced by human multiple myeloma cells 78
CXCR3 and its binding chemokines in myeloma cells: expression of isoforms and potential relationships with myeloma cell proliferation and survival. 78
Myeloma cells inhibit the non-canonical wnt co-receptor ror2 in human mesenchymal/osteoprogenitor cells: effect of wnt5a/ror2 pathway activation on mm-induced impairment of the osteogenic differentiation process 78
Macrophage inflammatory protein (MIP)-3 alpha/CCL20 and its receptor CCR6 are overexpressed in the bone microenvironment and involved in osteoclast formation in multiple myeloma patients. 78
Pan-aurora kinase inhibitor MK-0457 synergistically potentiates Apo2l/TRAIL cytotoxicity in Multiple Mieloma cells sensitive and resistant to bortezomib 77
Production of Wnt inhibitors by myeloma cells: potential effects on canonical Wnt pathway in the bone microenvironment 76
In vitro and In vivo evidences of osteocytes involvement in myeloma-induced osteolysis 76
Bleomycin Genotoxicity and Amifostine (WR-2721) Cell Protection in Normal Leukocytes versus K562 Tumoral Cells 76
Autologous bone marrow transplantation in acute myeloid leukemia: a single center experience 76
Human myeloma cells stimulate the receptor activator of nuclear factor-kappa B ligand (RANKL) in T lymphocytes: a potential role in multiple myeloma bone disease 76
DNA damage by tobacco smoke and some antiblastic drugs evaluated using the Comet assay 75
A translocation t(4;13)(q21;q14) as single clonal chromosomal abnormality in a parathyroid adenoma 75
Increased osteocyte apoptosis in Multiple Myeloma patients: a potential role in bone remodeling alterations related to osteolytic bone lesions 74
Paracrine rather than autocrine basic FGF (bFGF) loop in multiple myeloma 73
Downmodulation of ERK protein kinase activity inhibits VEGF secretion by human myeloma cells and myeloma-induced angiogenesis 73
BCL2 oncogene protein expression in human hematopoietic precursors during fetal life. 73
Combined treatment with the MEK inhibitor PD0325901 and Arsenic Trioxide has potent anti-tumor activity in vivo against human multiple myeloma xenograft model. 72
The new tumor suppressor gene inhibitor of growth family member 4 (ING4) regulates the production of pro-angiogenic molecules by myeloma cells and suppresses hypoxia inducible factor (HIF)-1{alpha} activity being involved in myeloma-induced angiogenesis. 72
Differential sensitivity of adherent CFU-blast, CFU-mix, BFU-E, and CFU-GM to mafosfamide: implications for adjusted dose purging in autologous bone marrow transplantation. 72
Beta-catenin depended and independent effects induced by myeloma cells in human and murine osteoblasts and osteoblast progenitors. 71
Angiogenic switch in multiple myeloma 70
Bone osteoblastic and mesenchymal stromal cells lack primarily tumoral features in multiple myeloma patients 70
A distintive nuclear morfology in three cases of acute myeloid leukaemia associated with loss HLA-DR expression and FTL3 internal tandem duplication 70
Human myeloma cells production of angiopoietin-1 and its potential relationship with myeloma-induced angiogenesis 69
Association of folate transporter SLC19A1 polymorphisms with the outcome of multiple myeloma after chemotherapy and tandem autologous transplantation. 69
p29ING4 regulates the production of pro-angiogenic molecules by human myeloma cells in normoxic and hypoxic conditions being involved in myeloma-induced angiogenesis. 69
EPIRUBICIN PLUS G-CSF ELICITED PERIPHERAL BLOOD PROGENITOR CELL MOBILIZATION IS SIGNIFICANTLY ENHANCED BY AMIFOSTINE 68
IL-7 is produced by myeloma cells in presence of IL-6 68
Multiple myeloma patient with unusual extramedullary involvement 68
Human myeloma cells express IL-7 mRNA and secrete IL-7 in presence of IL-6 67
Osteogenic differentiation of mesenchymal stem cells in multiple myeloma: identification of potential therapeutic targets 67
Assessment of the efficacy of a last-generation polyvalent immunoglobulin in the treatment of idiopathic thrombocytopenic purpura. 67
Human myeloma cells produce angiopoietin-1: potential relationship with myeloma-induced angiogenesis 66
Down-modulation of ERK protein kinase activity suppresses human myeloma cell proliferation and myeloma-induced angiogenesis by VEGF inhibition 66
Expression of pro-angiogenetic factors by myeloma cells: role of the angiopoietin system 65
Purging the bone marrow in non-Hodgkin's lymphomas. Is there any evidence of its value? 65
The proteasome inhibitor bortezomib affects osteoblastogenesis and bone formation in vitro and in vivo in multiple myeloma patients. 65
VACOP-B, high-dose cyclophosphamide and high-dose therapy with peripheral blood progenitor cell rescue for aggressive non-Hodgkin's lymphoma with bone marrow involvement: a study by the non-Hodgkin's Lymphoma Co-operative Study Group 64
Laparoscopic splenectomy: comments on the surgical technic 64
RANKL is critically involved in the physiopathology of multiple myeloma 64
HUMAN MYELOMA CELLS EXPRESS THE BONE REGULATING GENE RUNX2/CBFA1 AND PRODUCE OSTEOPONTIN THAT IT IS INVOLVED IN MYELOMA INDUCED ANGIOGENESIS 63
Evaluation of amifostine (WR-271) cytoprotection against in vitro bleomycin-induced clastogenicity in human leukocytes by SCGE assay 63
Bone marrow transplantation in patients with acute leukemia 63
Gamma-rays from Mössbauer sources: a low-dose approach to cancer therapy 63
Autotransplantation in acute leukemia. 63
Clonogenic potential and phenotypic analysis of CD34+ cells mobilized by different chemotherapy regimens 63
Paracrine rather than autocrine basic FGF (bFGF) loop in multiple myeloma 62
Down-modulation of ERK protein kinase activity inhibits vascular endothelial growth factor (VEGF) secretion by human myeloma cell lines 62
MYELOMA CELLS BLOCK RUNX2/CBFA1 ACTIVITY IN HUMAN BONE MARROW OSTEOBLAST PROGENITORS AND INHIBIT OSTEOBLAST FORMATION AND DIFFERENTIATION 61
DKK-1 and sFRP-3 expression by myeloma cell and bone marrow plasma levels in multiple myeloma and MGUS patients: Potential relationship with bone status. 61
Non-infusional vs intravenous consolidation chemotherapy in elderly patients withacute myeloid leukemia: final results of the EORTC-GIMEMA AML-13 randomized phase 61
The proteasome inhibitor bortezomib stimulates the osteogenic differentiation of mesenchymal cells in vitro and may increase osteoblast formation in vivo in multiple myeloma patients. 60
Interleukin-3 (IL-3) is overexpressed by T lymphocytes in multiple myeloma patients 59
Do human myeloma cells directly produce the receptor activator of nuclear factor kappaB ligand (RANKL) or induce RANKL in the bone marrow microenvironment? 58
Effects of Mössbauer radiation on bone marrow cultures 58
Primitive hematopoietic progenitors within mobilized blood are spared by uncontrolled rate freezing 58
Targeting pathways mediating bone disease. 58
The RANK/RANK ligand system is involved in interleukin-6 and interleukin-11 up-regulation by human myeloma cells in the bone marrow microenvironment 58
CD34+ cells mobilized by cyclophosphamide and granulocyte colony-stimulating factor (G-CSF) are functionally different from CD34+ cells mobilized by G-CSF. 58
Basic fibroblast growth factor (bFGF) production and role in multiple myeloma patients 57
Limited engraftment capacity of bone marrow-derived mesenchymal cells following T-cell-depleted hematopoietic stem cell transplantation 57
TRAPIANTO DI CELLULE STAMINALI EMOPOIETICHE 57
Role of tumor necrosis factor-related activation-induced cytokine (TRANCE) in multiple myeloma 56
Totale 7.630
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.346
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.346
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.020 0 0 0 0 0 178 258 35 156 192 54 147
2020/20211.166 21 142 113 4 157 6 120 9 274 37 254 29
2021/2022784 11 2 5 56 16 31 94 137 35 85 80 232
2022/20232.743 357 295 171 193 250 284 53 151 891 11 74 13
2023/2024866 40 105 21 16 75 196 82 89 22 41 69 110
2024/20251.225 52 178 198 202 313 282 0 0 0 0 0 0
Totale 10.375